Kirolos Adly
Psychiatry · Biloxi, MSNPI 1891360384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $36.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$876
- Otsuka America Pharmaceutical, Inc.$805
- Neurocrine Biosciences, Inc.$720
- Lundbeck LLC$415
- Johnson & Johnson$389
- plus $2K from 10 others
What the payments were for
- Food & beverage$6,096100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $1,241 |
| Alkermes, Inc. | 17 | $876 |
| Otsuka America Pharmaceutical, Inc. | 19 | $805 |
| Neurocrine Biosciences, Inc. | 22 | $720 |
| Lundbeck LLC | 18 | $415 |
| Johnson & Johnson | 10 | $389 |
| Vanda Pharmaceuticals Inc. | 6 | $339 |
| E.r. Squibb & Sons, L.L.C. | 9 | $331 |
| Avanir Pharmaceuticals, Inc. | 9 | $223 |
| Axsome Therapeutics, Inc. | 2 | $223 |
| Livanova USA, Inc. | 2 | $154 |
| AbbVie | 5 | $132 |
| Bioxcel Therapeutics, Inc. | 2 | $115 |
| Indivior Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Stryker | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,467
- ARISTADA$905
- REXULTI$249
- ABILIFY MAINTENA$246
- ABILIFY ASIMTUFII$246
- INGREZZA$245
- Austedo XR$230
- ARISTADA INITIO$226
- VNS Therapy Symmetry Model 8103 Generator$130
- NUEDEXTA$125
- Auvelity$124
- Fanapt$123
- UZEDY$122
- COBENFY$113
- INVEGA SUSTENNA$101
How this compares
$6,096 in reported general payments places this provider in the 90th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 19 | $150,260 |
| Abilify MaintenaAripiprazole | 22 | $65,855 |
| UzedyRisperidone | 17 | $62,952 |
| TrintellixVortioxetine Hydrobromide | 11 | $6,531 |
| Haloperidol Decanoate | 14 | $768 |
| Aripiprazole | 33 | $664 |
| Quetiapine Fumarate | 27 | $560 |
| Ziprasidone Hcl | 13 | $536 |
| Trazodone Hcl | 82 | $530 |
| Prazosin Hcl | 39 | $469 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $452 |
| Chlorpromazine Hcl | 13 | $413 |
| Benztropine Mesylate | 32 | $390 |
| Fluphenazine Hcl | 11 | $359 |
| Olanzapine | 21 | $340 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $720 | $150,26019 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $805 | $65,85522 claims |
| Teva Pharmaceuticals USA, Inc.Uzedy | $1,241 | $62,95217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Biloxi
- Maxie GordonClinton$1.3M
- Kurt BuechlerRidgeland$1.1M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- John NortonJackson$173K
- Amy MillerSaltillo$82K
- Clyde GlennRidgeland$68K
- Krishan GuptaJackson$26K
- Joseph KwentusFlowood$13K
- Mark WebbRidgeland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.